Keith Orford
Director/Board Member chez CALITHERA BIOSCIENCES, INC.
Fortune : 1 $ au 31/03/2024
Profil
Dr. Keith Orford is a Chief Medical Officer, Executive VP-Clinical at Fog Pharmaceuticals, Inc. He is on the Board of Directors at Calithera Biosciences, Inc. He received his doctorate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2023 | 54 ( 0,00% ) | 1 $ | 31/03/2024 |
Postes actifs de Keith Orford
| Sociétés | Poste | Début |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 05/11/2021 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
Formation de Keith Orford
| Georgetown University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
